We’ve known that red wine confers health benefits for years, but here’s a new one: researchers at the Cleveland Clinic, led by Charis Eng, MD, Ph.D., Chair of the Genomic Medicine Institute, have found that red wine boosts the effects of a common drug used to treat breast cancer. The drug is rapamycin, and the compound in the wine is, of course, resveratrol. The latter compound seems to be the active ingredient in red wine that drives most of its health benefits. Continue reading “Red Wine Gives Boost to Breast Cancer Drug”